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Muscarinic and Nicotinic
Contribution to Contrast Sensitivity
of Macaque Area V1 Neurons
Jose L. Herrero †, Marc A. Gieselmann and Alexander Thiele*
Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom
Acetylcholine is a neuromodulator that shapes information processing in different cortical
and subcortical areas. Cell type and location specific cholinergic receptor distributions
suggest that acetylcholine in macaque striate cortex should boost feed-forward driven
activity, while also reducing population excitability by increasing inhibitory tone. Studies
using cholinergic agonists in anesthetized primate V1 have yielded conflicting evidence
for such a proposal. Here we investigated how muscarinic or nicotinic receptor blockade
affect neuronal excitability and contrast response functions in awake macaque area V1.
Muscarinic or nicotinic receptor blockade caused reduced activity for all contrasts tested,
without affecting the contrast where neurons reach their half maximal response (c50). The
activity reduction upon muscarinic and nicotinic blockade resulted in reduced neuronal
contrast sensitivity, as assessed through neurometric functions. In the majority of cells
receptor blockade was best described by a response gain model (a multiplicative scaling
of responses), indicating that ACh is involved in signal enhancement, not saliency filtering
in macaque V1.
Keywords: acetylcholine, visual cortex organization, contrast sensitivity, normalization, primary visual cortex (V1)
INTRODUCTION
Acetylcholine (ACh) contributes to sensory processing and to high level cognitive functions across
cortical areas. Its action in the primate is probably best studied in primary visual cortex (V1). In V1,
ACh application increases neuronal orientation and direction selectivity (Sillito and Kemp, 1983;
Sato et al., 1987; Sillito and Murphy, 1987), it increases contrast sensitivity in layer IV by acting
on nicotinic receptors (Disney et al., 2007), sharpens spatial tuning (Roberts et al., 2005), reduces
firing rate variability and reduces neuronal noise correlations (Goard and Dan, 2009). Moreover, it
increases attentional modulation (Herrero et al., 2008), population coding abilities (Minces et al.,
2017; van Kempen et al., 2017), and it improves behavioral performance (Pinto et al., 2013; Gritton
et al., 2016).
In light of this literature, it is surprising that some of the basic effects of cholinergic activation
on neuronal firing rates remain disputed (Bhattacharyya et al., 2012; Disney et al., 2012; Soma
et al., 2012). Disney et al. (2007, 2012) report overall decreased activation of macaque V1
neurons upon ACh application outside of the thalamo-recipient layers, and increased activation
in thalamo-recipient layers. Conversely, Soma et al. (2012) report an overall facilitatory effect
of ACh application in macaque V1 neurons across cortical layers, which was predominantly
mediated by muscarinic receptors. The latter is similar to data from the tree shrew, where nicotinic
and muscarinic activation increases neuronal activity across all layers, even if overall magnitude
differences exist between layers (Bhattacharyya et al., 2012).
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All of these studies (Bhattacharyya et al., 2012; Disney et al.,
2012; Soma et al., 2012) assessed contrast response function,
through application of non-specific or specific cholinergic
agonists (in parts simultaneously with selective antagonists)
in anesthetized animals. Discrepancies could possibly arise
from differences in anesthesia regime or depth of anesthesia,
particularly in light of the known state dependency of cholinergic
activation (Harris and Thiele, 2011). Moreover, the studies
conducted in macaques do not explicitly dissect the role
of muscarinic vs. nicotinic receptors (mAChR and nAChR,
respectively) on excitability or contrast sensitivity, which requires
selective blockade of these.
The conflicting results between Disney et al. (2012) and
Soma et al. (2012) also have fundamentally different implication
regarding the function cholinergic activation serves in V1. ACh
induced increases of sensitivity in thalamocortical recipient
layers, combined with muscarinic induced response reduction
outside layer 4, could result in enhancement of strong stimuli,
and filtering out of weak stimuli, i.e., a mechanism that helps
saliency detection akin to the proposed roles of noradrenaline
(Figure 1A for a cartoon, Aston-Jones and Cohen, 2005).
Moreover, this scenario could also indicate that ACh is involved
in contrast or other forms of normalization (Heeger, 1992;
Carandini et al., 1997; Lee and Maunsell, 2009; Reynolds and
Heeger, 2009; Carandini and Heeger, 2012; Ni et al., 2012; Ray
et al., 2013; Sanayei et al., 2015). Conversely, the effects seen
in layer 4, in conjunction with muscarinic induced sensitivity
increase outside layer 4, would cause an increase in neuronal
gain and thus an overall sensitivity enhancement (Figure 1B for
a cartoon).
To address these issues, we investigated the effects of
muscarinic and nicotinic receptor blockade (and by proxy their
activation) on V1 neurons in awake animals. By fitting a
variety of different models to our data, and performing model
evaluation, we aimed to gain insight into the mechanisms by
which these receptors contribute to contrast sensitivity, namely
whether they best support a signal enhancement role of ACh
or a saliency filtering role. We recorded contrast response
functions in area V1 in macaque monkeys, while they performed
a passive fixation task under control conditions and while
scopolamine (muscarinic blocker) or mecamylamine (nicotinic
blocker) were iontophoretically applied in the immediate vicinity
of the neurons under study.
METHODS
Three male rhesus monkeys (male 5–8 years old) were used for
the electrophysiological recordings reported in this study. After
initial training, monkeys were implanted with a head holder
and recording chambers above V1 under general anesthesia
and sterile conditions (for details of surgical procedures, post-
surgical analgesics and general post-surgical treatment see Thiele
et al., 2006). All procedures complied with the European
Communities Council Directive RL 2010/63/EC, the US National
Institutes of Health Guidelines for the Care and Use of Animals
for Experimental Procedures, and the UK Animals Scientific
Procedures Act. They were approved by the Newcastle University
AWERB committee.
Electrophysiological Recordings and Drug
Application
The details of our iontophoretic approaches have been published
before (Herrero et al., 2008). They are repeated here for ease of
access.
A tungsten-in-glass electrode flanked by two pipettes was
used for the recordings (Thiele et al., 2006). Drugs were applied
iontophoretically through these pipettes (NeuroPhore BH-2,
Digitimer,WelwynGardenCity, Hertfordshire, England). Pipette
opening diameter varied between 1 and 4µm. Pipette resistance
varied between 12 and 150 M, with most recordings at 20–80
M.
Pipette-electrode combinations were inserted into V1 through
the dura on a daily basis without guide tubes. The electrode
and the pipette integrity was checked by visual inspection under
the microscope before and after the recording sessions, and
by measurements of the pipette impedance before and after
the recording at each recording site. Drug application was
continuous during blocks of “drug applied.” The duration of
each block could vary depending on the number of repetitions
for each condition that we aimed for, and depending on the
number of eye fixation errors that the monkey made. On average
drug application for each block was ∼7–12min. For the data
analysis we removed the first 2 trials of each condition (8
contrasts and 2 drug states) from the data set (i.e., the first 32
trials of each block) as drug effects and recovery usually occur
with a slight delay. Drugs (SIGMA Aldrich) were dissolved in
distilled water. The details regarding drug concentration, pH, and
application current were: scopolamine (0.1M, pH 4.5, median
current strength: 30 nA, 25 percentile: 15 nA, 75 percentile:
45 nA), and mecamylamine (0.1M, pH 4.5, median current
strength: 10 nA, 25 percentile: 15 nA, 75 percentile: 5 nA).
In all experiments we regularly compensated for the change
in current during the ejection condition by increasing the hold
current of one of the two pipettes, thereby keeping the overall
current identical between the “hold” and “eject” conditions. This
ensured that overall current level between “hold” and “eject” were
identical, and therefore none of the effects described in the paper
can be due to direct current effects. In addition we performed
“sham” injections at a few sites in V1, by filling the barrels
with saline of identical pH (4.5) and recording the neuronal
activity under “hold” and “eject” conditions. None of these sham
injections resulted in any significant changes to the neuronal
activity.
Data Collection
Stimulus presentation and behavioral control was managed by
Remote Cortex 5.95 (Laboratory of Neuropsychology, National
Institute for Mental Health, Bethesda, MD, https://www.nimh.
nih.gov/labs-at-nimh/research-areas/clinics-and-labs/ln/shn/
software-projects.shtml). Neuronal data were collected by
Cheetah data acquisition (Neuralynx, Bozeman, MT) interlinked
with Remote Cortex. The waveforms of all spikes that exceeded a
threshold set by the experimenter were sampled at 32 kHz. Spike
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FIGURE 1 | Potential role of cholinergic neuromodulation. (A) If acetylcholine was involved in a form a saliency enhancement, the prediction would be that weak
stimuli (low contrast) are suppressed by high levels of acetylcholine, while strong stimuli would be enhanced. (B) If acetylcholine was involved in sensitivity
enhancement, then all stimuli (weak and strong) would be processed more efficiently.
data from the recording electrode were obtained by band-pass
filtering the raw signal from 600–9000Hz. To obtain single unit
data, offline sorting of these spike samples was carried out based
on waveform features (Neuralynx spike sorting software and
customMatlab scripts).
Behavioral Task and Stimuli
Display
All stimuli were presented against a gray background (21 cd/m2)
on a 20 inch analog cathode ray tube (CRT) monitor (100Hz;
1,600 × 1,200 pixels; 57 cm from the animal). Eye position
was recorded with an infrared-based camera system (Thomas
Recording) and sampled at a rate of 250Hz. The maximum
luminance for 64% contrast stimuli was 34.45 cd/m2, while the
minimum luminance was 7.55 cd/m2.
RF Mapping
At the beginning of each recording receptive fields were mapped
using a reverse correlation technique described previously
(Gieselmann and Thiele, 2008). The RFs recorded had an
eccentricity of 3–6◦, with the majority at∼4.0◦.
Contrast Response Functions
A trial started as soon as the monkey’s eye position was within
a fixation window centered on the fixation point. Following
a 500ms pre-stimulus period, a Gabor grating was presented
for 700ms, centered on the neuron’s RF. The orientation and
spatial frequency of the Gabor matched the neuron’s orientation
and spatial frequency preference, as determined by a reverse
correlation technique (Gieselmann and Thiele, 2008). The Gabor
moved within a Gaussian aperture at 4Hz temporal frequency.
The motion was perpendicular to the Gabor’s orientation, and
reversed direction at a frequency of 4Hz (∼3 time reversals
during the 700ms presentation). The contrast of the Gabor was
varied between 0, 4, 8, 12, 16, 24, 32, and 64% (Michelson
contrast). Following stimulus presentation the fixation point
disappeared and monkeys were rewarded if their eye position
had been within the fixation window (see below) for the
trial duration. Twenty trials per stimulus, contrast, and drug
application condition were recorded in most recordings. Cells
were excluded if fewer than 10 trials per stimulus (contrast), and
drug application conditions were available.
For all recordings eye movements were recorded by an
infra-red based system (Thomas Recording, temporal resolution
220Hz, spatial resolution 2.5′). Eye position during all trials was
restricted to be within±0.5–0.7◦ of the fixation point.
Data Analysis
First, we analyzed activity in trials before a drug was applied
(i.e., trials during the baseline period). In the context of this
paper we used the response period from 200 to 700ms after
stimulus onset for analysis because of our interest in the steady-
state response. However, we confirmed the generality of our
findings by also analyzing the responses in the period form 50–
200ms after stimulus onset. Using this window gave qualitatively
identical results to those reported for the 200–700ms response
window. Stability of recording (i.e., absence of slow drifts over
time) was assessed by calculating a correlation between firing
rates (separately for the no drug and the drug conditions) against
trial number. Neurons were included if the correlation for all
16 conditions (8 contrasts ∗2 drug states) was not significant
(p > 0.05/16 = 0.003125; assuming non-significant changes
over time after correction for multiple comparison). A total of
74 cells investigated with and without scopolamine application
passed this assessment, and 41 cells investigated with and without
mecamylamine application passed this assessment.
Sorted spikes were plotted for each contrast aligned to
stimulus onset, and peri-stimulus time histograms (PSTH) were
calculated for each condition using 1ms bin resolution, whereby
each spike was convolved with a 20ms Gaussian envelope for
smoothing (see Figure 2 for examples). These plots were visually
inspected as an additional control for recording stability (in
addition to the quantitative drift measure analysis described
above). Single cell histograms were used to compile population
histograms (Figure 3) for the different conditions.
Mean firing rates were calculated for each cell and condition
in the time window from 200 to 700ms after stimulus onset.
Spontaneous activity was calculated in a time window from−300
to 0ms before stimulus onset.
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FIGURE 2 | Examples of drug effects on neuronal activity across different stimulus contrast. (A) Cell that was measured under control conditions (blue) and when
scopolamine was locally applied (red). (B) Cell that was measured under control conditions (blue) and when mecamylamine was locally applied (red). Ips: impulses per
second.
Contrast response functions (Naka-Rushton) were calculated
for each cell and drug condition by fitting the following
formula.
R (C) = Rmax ∗
cn
(cn + c50n)
+M (1)
to the data, whereby the fitted parameters were: Rmax is the
saturated (maximal) response, c50 is the contrast at which the
half maximal response is reached, n determines the slope of
the contrast response function at c50, and M corresponds to
the baseline activity. The model has been successfully used to
describe contrast response functions in monkey visual cortex
(Albrecht and Hamilton, 1982; Thiele et al., 2000; Williford and
Maunsell, 2006). We used non-linear minimization to minimize
the summed squared difference between data and model
(fminsearch, Matlab 7.1, Mathworks), whereby we constrained
the M to be ≥0, c50 to be in the interval [2 50], n to be in
the interval [0.1 10], and Rmax to be smaller than 1.5 times
the maximum response measured for a given cell. To determine
whether any of the fitted parameters differed for the non-drug
and the drug condition, we fitted each function independently
with the Naka-Rushton function.
Effect of Cholinergic Modulation on
Neurometric Functions
We quantified the effect of cholinergic modulation on neuronal
sensitivity by calculating neurometric functions for each cell
under control and drug applied conditions. This was done
by calculating the Area Under the Receiver Operating Curve
(AUROC) for each contrast, by comparing it to the 0% contrast
condition (time window for analysis: 200–700ms after stimulus
onset). This yields an AUROC value of 0.5 for the 0% contrast
condition, and values that can differ from 0.5 for all other contrast
conditions. We fitted these AUROC data with aWeibull function
(maximum likelihood estimation):
AUROC = 1−
(
0.5 ∗ e(
c
α )
β
)
(2)
where “AUROC” corresponds to AUROC value measure, or
the probability correct of an ideal observer performance, “c” is
stimulus contrast, “α” corresponds to contrast threshold (∼82%
ideal observer performance) and “β” corresponds to the slope of
the function at threshold.We fitted this function separately to the
two data sets (control and drug applied, respectively), and also
fitted a single function to the joint data set, i.e., forcing α and
β to attain the same value for the two conditions. This yielded
separate goodness of Weibull fits (χ2) and a single goodness of
Weibull fit (χ2). If the joint fit was as good as the fit to the separate
data sets (i.e., if the χ2 for the common fit was not significantly
different from the χ2 for separate data sets, χ2 distribution;
degrees freedom = 2; p > 0.05), the thresholds for control and
the drug condition were deemed indistinguishable. By contrast, if
a common fit was worse than separate fits (p < 0.05), thresholds
for the two conditions were considered significantly different
(Watson, 1979; Thiele et al., 2000).
Frontiers in Neural Circuits | www.frontiersin.org 4 December 2017 | Volume 11 | Article 106
Herrero et al. Cholinergic Contribution to Contrast Sensitivity
FIGURE 3 | Raw and normalized population histograms of drug effects on neuronal activity across different stimulus contrast. (A) Population activity under control
conditions (blue) and when scopolamine was locally applied (red). Upper row shows non-normalized population activity, lower row shows normalized population
activity (normalized to maximum for each cell). (B) Population activity under control conditions (blue) and when mecamylamine was locally applied (red). Upper row
shows non-normalized population activity, lower row shows normalized (for each cell) population activity. Solid lines show mean activities, shaded areas S.E.M (which
sometimes was too small to be visible).
Model Evaluation
To determine whether the effects of cholinergic modulation are
best captured by a response gain model, a contrast gain model,
an additive model, or normalization models the control and drug
data were jointly fit with the following equations:
Response gain model:
Control Condition: R (C) = Rmax ∗
cn
(cn + c50n)
+M (3)
Drug Condition: R (C) = drug ∗ Rmax ∗
cn
(cn + c50n)
+M
Contrast gain model:
Control Condition: R (C) = Rmax ∗
cn
(cn + c50n)
+M (4)
Drug Condition: R (C) = Rmax ∗
cn(
cn + drug ∗ c50
n
) +M
Additive model:
Control Condition: R (C) = Rmax ∗
cn
(cn + c50n)
+M (5)
Drug Condition: R (C) = Rmax ∗
cn
(cn + c50n)
+ drug ∗M
Normalization model:
Control Condition: R (C) = Rmax ∗
cn
(cn + c50n)
+M
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Drug Condition: R (C) = drug∗ Rmax
∗
cn(
drug ∗ cn + c50n
) +M (6)
Saliency filter (slope) model:
Control Condition: R (C) = Rmax ∗
cn
(cn + c50n)
+M (7)
Drug Condition: R (C) = Rmax ∗
cdrug ∗ n(
cdrug
∗ n + c50drug ∗ n
) +M
Where the different parameters were as described in equation 1,
except for the additional parameter “drug.” This single additional
free parameter occurs for the drug applied condition, and it can
affect the contrast dependent responses. Note that all models have
exactly the same number of free parameters. To determine which
model best described the effect on a given cell, we calculated
the χ2-error for each of these functions and performed model
evaluation by Akaike’s information criterion (AIC, Burnham and
Anderson, 2004):
AIC = χ2 + 2k (8)
where k corresponds to the number of free parameters in the
model, i.e., 5 respectively. We thus obtained AIC1 to AIC5 for
each cells, and calculated Akaike weights (wi) for final model
comparison:.
wi =
e(− δi2 )∑5
n=1 e(−
δn
2 )
(9)
Here, δi corresponded to the AICi-AICmin, where AICmin was the
smallest AIC obtained for the 5 model fits. The larger the wi, the
more evidence existed in favor of model i.
Additionally we calculated how much variance each model
accounted for (Carandini et al., 1997; Roberts et al., 2005, 2007),
and used this as an additional measure to assess whichmodel best
described the data overall.
RESULTS
We recorded contrast tuning curves for 74 cells under control
conditions and when scopolamine was applied, and for 41 cells
under control conditions and when mecamylamine was applied.
Figure 2 shows responses from 2 example cells. For both cells
the activity increased with increasing contrast (p < 0.001, 2
factor ANOVA), and drug application reduced neuronal activity
(p < 0.001, 2 factor ANOVA). These cells exemplify the pattern
found across our neuronal populations (Figure 3).
To assess the drug effects quantitatively we calculated the
mean rate for each cell in the time window from 200 to
700ms after stimulus onset for each contrast and drug condition,
and also for the pre-stimulus period from −300 to 0ms.
These data are shown in Figure 4. We calculated a 2 factor
repeated measures (RM) ANOVA (factor1: contrast, factor 2:
drug application) to determine whether contrast and/or drug
FIGURE 4 | Effect of muscarinic and nicotinic receptor blockade on neuronal
firing rates at different stimulus contrasts and for spontaneous activity.
(A) Effect of muscarinic receptor blockade (scopolamine application) on
neuronal firing rates at different Gabor contrasts. (B) Effect of nicotinic receptor
blockade (mecamylamine) on neuronal firing rates at different Gabor contrasts.
(C) Effect of muscarinic receptor blockade on spontaneous activity. (D) Effect
of nicotinic receptor blockade on spontaneous activity. Blue symbols show
mean ± S.E.M of control activity, red symbols show mean ± S.E.M of drug
applied activity. P-values indicate significance, number of cells recorded is
indicated by the insets “n.”
significantly affected firing rates, and whether there was a
significant interaction between these. Drug effects on the pre-
stimulus period were assessed with a paired t-test. As expected,
contrast significantly affected firing rates (p < 0.001, 2 factors
RMANOVA).Moreover, muscarinic as well as nicotinic blockade
significantly affected firing rates (p < 0.001, 2 factors RM
ANOVA). In both cases we found a significant interaction
between contrast and drug application. Figure 4 shows that
drug induced reduction was larger for higher firing rates
(higher contrast). Neither drug affected spontaneous activity
(scopolamine: p= 0.33, mecamylamine: p= 0.602, paired t-test).
As stated, Figure 4 shows that drug induced reduction was
larger for higher firing rates (higher contrast), which suggests that
drug application mostly resulted in a proportional scaling of the
contrast response function, rather than a shift to either the left or
right, or a change in the overall slope. To quantify this across the
population of cells, we fitted each cell’s responses with a Naka-
Rushton function (methods). This allows determining whether
the maximum response (Rmax), the location of the half maximal
response (c50), the slope of the contrast response function (n),
or the offset (M) was affected by drug application. The results
are shown in Figure 5. It shows that the only parameter of the
Naka-Rushton function significantly affected by drug application
was the maximal response (Rmax), which was reduced when
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either muscarinic receptors (Figure 5A), or nicotinic receptors
were blocked (Figure 5B). The results held also, when only cells
significantly affected by drug application were included in the
analysis [see p(sig) insets in Figure 5], although there was a trend
for a significant change of the c50 location (an increase in c50)
when nicotinic receptors were blocked (p = 0.088), provided
significantly affected cells were analyzed.
Neuronal Discrimination Abilities
While the previous analyses reveal that nicotinic and
muscarinic receptor blockade affect neuronal contrast response
functions, they do not yield insight into how this would affect
discrimination abilities. For example changes in Rmax or c50
on their own do not provide information about sensitivity
per se, even though they may hint that these would be affected.
This is because the half maximal response of a neuron does
not relate in a meaningful to neuronal discriminability, as it
ignores e.g. maximum firing rate in relation to baseline firing
rate and rate variability. For example, if drug induced changes
were minimal or absent at relatively low contrasts, neuronal
discrimination (detection) abilities might still be unaffected.
To quantify neuronal discrimination/detection abilities we
calculated AUROCs and fitted Weibull functions to the drug
applied and the drug not applied data (see methods). We thus
obtained neurometric functions (Britten et al., 1992; Thiele
et al., 2000) for each cell for the different drug conditions. From
these fits we obtained estimates of neuronal sensitivity (neuronal
thresholds) and of the slope of the Weibull function at threshold.
The results are shown in Figure 6.
AUROC values were (largely) lower when the drugs were
applied for both, the muscarinic and the nicotinic blockade.
The effects overall appeared larger when muscarinic receptors
were blocked than when nicotinic receptors were blocked.
Thresholds of the Weibull function fits are defined as the
ability of an ideal observer to detect the stimulus with an
accuracy of 82%. Median thresholds were 9.62% and 11.5%
contrast for the control and the scopolamine applied conditions.
They were 10.0% and 10.7% contrast for the control and the
mecamylamine applied condition. Blockade of muscarinic and
nicotinic receptors resulted in significantly increased thresholds
when considering the entire sample of cells, i.e., reduced neuronal
sensitivity (see p-value insets in Figures 6B,E, Wilcoxon sign
rank test). Considering only those cells where separate fits yielded
significantly better fits than a joint fit, the thresholds were
significantly increased when muscarinic receptors were blocked,
and a trend toward a significant increase was observed when
nicotinic receptors were blocked. The slope at threshold was
not significantly affected by drug application for either of the
conditions, although there was a trend for increased slopes when
all cells were taken into account for the muscarinic blockade
condition (Figure 6C).
Model Evaluation
The data shown in Figure 5 do not address the question whether
the effects of drug application are best explained by response
gain, contrast gain, additive, normalization models, or slope
gain models. To address this quantitatively, we fitted each cell’s
responses with response gain, contrast gain, additive gain, a
normalization and a slope gain model. We calculated AIC
weights and variance accounted for, for each model to determine
which of the models yielded the best model fit for a given
cell. The largest AIC weight indicates which model has the
best evidence (across the models applied). Moreover, the largest
average variance accounted for gives an indication which model
best fits that majority of cells. In this analysis we focus on
cells where drug application had a significant effect on neuronal
activity. The reason for this is that cells not affected by drug
application, should in principle be equally well fit by any of the
models as the drug parameter (see methods) should be 1 in that
case, which would make all the models identical.
Example cells where one model gave better fits than other
models are shown in Figure 7. It shows two examples where
the response gain yielded the best fits, on example where the
normalization model yielded the best fit, one example where
contrast gain, and one example where the additive gain model
yielded the best fit.
The percentages of cells best fit by the different models are
shown in Figure 8. When muscarinic receptors were blocked,
most of the cells were best fit by a response gain model (71%),
followed by additive gain, contrast gain, normalization, and
slope models. The percentage of the latter gain models was
comparatively small (12, 8, 6, and 2%, respectively). A similar
picture emerges when analyzing the data for nicotinic blockade.
The majority of cells from this data set were equally best fit
by a response gain model (74%), followed by the contrast gain
(17%), additive and normalization gain models (4% each). The
slope gain model only ever best described the data in 1/66
significantly affected cells across both drug conditions. The best
fit counts (number of cells) for the different models were not
different between the two drug conditions [χ2 = 1.717, df = 4,
χ2/df = 0.43, P(χ2>1.717) = 0.7876)]. Figure 8 additionally shows
the distributions of AIC weights, and the variance accounted
for, across the models. The response gain models on average
had larger AIC weights than the other models. This is the case
even though all models yielded fairly good fits to the data (as
evidenced by the fairly large values of variance accounted for,
see also the examples in Figure 7). Finally, triplet wise AIC
weight comparisons are shown between different models in
Figure 8 (bottom rows). These plots show that the majority of
AIC weights are clustered toward large values (close to 1) for the
response gain models. Thus, response gain models best describe
the action of ACh for the majority of cells in macaque area V1.
Nicotinic and muscarinic receptor stimulation would increase
response gain.
DISCUSSION
Here we investigated the effects of muscarinic and nicotinic
blockade on V1 contrast responses. Both manipulations reduced
neuronal responses and reduced neuronal sensitivity. Fitting the
data with different gain models indicates that nicotinic receptors
and muscarinic receptors mostly affect contrast sensitivity by
response gain changes.
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FIGURE 5 | Effect of muscarinic and nicotinic receptor blockade on parameter values of the fitted contrast response function (NAKA-Rushton) for the control and the
drug applied conditions. (A) Effect of muscarinic receptor blockade on the contrast at the half maximal response, (c50), the slope of the function (n), the maximal
response (Rmax), and the response offset (estimated spontaneous activity). (B) Same as in (A), but for nicotinic receptor blockade. Black symbols show the fitted
parameter values for all recorded cells, red symbols for cells where drug application had a significant effect on their firing rate. Red square symbol shows the median
of the parameter estimate for cells significantly affected by drug application, dashed red lines show 10 and 90% percentiles. P-values indicate whether parameter
estimates differ significantly between control and drug applied conditions when all cells were taken into account [p(all)] and when only cells significantly affected by the
drug application were taken into account [p(sig)].
In the following discussion we will mostly focus on data
derived from in vivo studies. Many previous studies used
indirect measures to assess the contribution of mAChRs or
nAChR to neuronal sensitivity. They often applied non-selective
agonists either alone or in conjunction with nAChR or mAChR
antagonists. The reduction or absence of effects when antagonists
were co-applied served as an indicator that effects seen were
receptor selective. We will discuss these studies as if the receptors
had been selectively activated or suppressed, and thereby follow
the preferred interpretations given by the respective authors.
Basic Effects of Nicotinic Manipulation
Most studies have reported that increased nicotinic drive in
cortical areas results in increased stimulus driven activity. No
controversy exists in this respect for layer IV (Disney et al.,
2007; Bhattacharyya et al., 2012; Soma et al., 2012). However,
outside layer IV, Disney et al. (2007) reported that nicotinic
activation resulted in reduced neuronal activity, while Soma et al.
(2012) reported increased activity across all cortical layers (even
though they argued that the main facilitation was mediated by
muscarinic effects, see below). Bhattacharyya et al. (2012) equally
found overall increased responses across all cortical layers upon
nicotinic and muscarinic stimulation in V1 of the tree shrew,
In a previous study, we found that nicotinic blockade caused
overall reduced activity in macaque V1 (Herrero et al., 2008),
which matches our results reported here. By inference, we would
predict that nicotinic activation would result in increased activity.
Neither our previous study, nor our current study could assign
recording sites to specific cortical layers, due to the nature of
day-to-day sampling of neurons in chronically implanted task
performing macaques. However, it is unlikely that our recordings
were predominantly in layer IV. Rather the daily access makes
it likely that a large proportion of neurons were recorded from
layers II and III. This assumption is based on the following.
The electrode would first traverse layers I, II, and III. Recording
normally commenced once good stimulus driven spiking activity
was obtained, as would be typical for layers II and III. Given that
a single recording required a fairly large number of trials, we
usually recorded only from 1 to 2 sites per day before the animals
stopped working. Thus, if our data are largely from layer II and
III, they would be in line with the results by Soma et al. (2012)
and Bhattacharyya et al. (2012), and less with those reported by
Disney et al. (2007, 2012).
Basic Effects of Muscarinic Manipulation
As is the case for nAChR manipulation, discrepant results
have been reported for the effects of mAChR on neuronal
excitability in V1. Herrero et al. (2008) found an overall reduction
of neuronal activity in V1 when mAChRs were blocked by
scopolamine, along with a reduction in attentional modulation
of V1 activity. Disney et al. (2007, 2012) found that outside
layer IV ACh application generally reduced neuronal activity.
This reduction was mediated by increased activity in inhibitory
cells. Based on the distribution of mAChRs and nAChRs they
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FIGURE 6 | Analysis of drug effects on neurometric functions. (A,D) AUROC values for the control (blue) and the drug (red) condition when scopolamine was applied.
(B,E) Neuronal thresholds derived from the Weibull fits to the AUROC values for the control (abscissa). (C,F) Slope of the Weibull function at the threshold location.
(A–C) show data when scopolamine was applied, (D–F) show data when mecamylamine was applied. Red dots show data were separate fits of the Weibull function
yielded significantly better fits to the data than a single combined fit to the two data sets. Black dots show those were a single fit was not significantly worse than
separate fits. P-value insets indicate whether the thresholds (slopes) derived from separate fits differed significantly for the control and the drug conditions (Wilcoxon
signed rank test). P(all) indicates the comparison when all cells were taken into account, p(sig) show the comparison for cells that were significantly better fitted with
separate functions.
inferred that the reduction was largely mediated by mAChRs
(Disney et al., 2012). Conversely, Soma et al. (2012) found that
cholinergic induced facilitation of activity in V1 was mediated
largely through muscarinic activation (with some nicotinic
contribution). Additionally, the small number of cells inhibited
by ACh, were also affected through muscarinic mechanisms.
Bhattacharyya et al. (2012) reported overall increased baseline
and stimulus induced activity across cortical layer (even if
less so in layer 4) upon muscarinic activation. Application of
scopolamine resulted in overall reduced neuronal activity in our
data set, which would be in line with the results reported by
Soma et al. (2012) and Bhattacharyya et al. (2012), but not by
Disney et al. (2012).
It is unclear how the discrepancy between studies arises. It
has been suggested that differences in anesthesia regimes might
contribute, but this can be ruled out for our study as it was
performed in awake task performing (passive fixation) monkeys.
Moreover, it could be due to differences in the dosages applied,
as Disney et al. (2012) reported differences when comparing low
vs. high ACh application currents. The currents used in our
study were relatively low, but since we used selective antagonists,
rather than agonists, direct current comparison is not possible.
However, Herrero et al. (2008) also applied ACh, and the currents
used in their study were usually on the low end of those applied
by Disney et al. (2012), where Disney et al found ACh induced
suppression. Herrero et al. (2008) reported ACh induced activity
increases. It is thus unlikely that the discrepancies between the
two studies can be explained by a switch from suppression to
facilitation once high levels of ACh were applied (as reported
by Disney et al., 2012). However, it is still possible that baseline
ACh levels differ strongly between anesthetized and awake
animals, and thus switches from facilitation to inhibition occur
at different application levels. Despite this, the overwhelming
number of studies reported that ACh application results on
increased activity in V1 (Sillito and Kemp, 1983; Sillito et al.,
1985; Sato et al., 1987; Roberts et al., 2005; Zinke et al., 2006;
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FIGURE 7 | Model comparison for example cells. Each row shows how well the 5 different models could be fitted to the control and drug applied activity levels. The
yellow insets highlight which particular model yielded the largest AIC weight. The different models are named at the top, the different drugs used in the particular
recording are indicated on the right.
Herrero et al., 2008; Goard and Dan, 2009; Kuo et al., 2009;
Rodriguez et al., 2010; Soma et al., 2012, 2013; Pinto et al., 2013),
and in other cortical areas (McKenna et al., 1988; Metherate
et al., 1988a,b; Matsumura et al., 1990; Tremblay et al., 1990;
Bhattacharyya et al., 2012, 2013; Thiele et al., 2012; Yang et al.,
2013; Major et al., 2015; Sun et al., 2017).
It is remains puzzling how an overall facilitation occurs
given that nicotinic and muscarinic somatic receptors reside
predominantly on inhibitory interneurons (Disney et al., 2006,
2014; Disney and Aoki, 2008; Disney and Reynolds, 2014). ACh
application should result in increased gabaergic drive and thus
reduced activity, as found by Disney et al. (2012). However, it
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FIGURE 8 | Model comparison at the population level by means of Aikake information criterion weights (AICw) and variance accounted for. Left column shows data
for cells tested with muscarinic blockade, right column shows data for cells tested with nicotinic blockade. Only cell significantly affected by drug application were
taken into account. (A,B) Percentage of cells where drug effects were best fit by one of the models employed (quantified by taking the largest AIC weights).
(C,D) Distribution of AIC weights and variance accounted for, given the different models. Red symbols denote means and standard deviation. (E,F) Triplet wise model
comparison that shows how AIC weights are linked for individual cells. Most data points are clustered towards high values for response gain models (they are often
overlayed on top of one another, which makes the crowding towards that location less apparent than really present).
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could be the case that the cortex can adjust its operational regime
to be always in a state of balanced excitation and inhibition. Thus,
changes to one component automatically result in changes to the
other component, through compensation mechanisms. Such an
increase in balanced excitation and inhibition can result in overall
increased excitability, which is manifests are changes in response
gain. It thereby also enhances coding abilities (Shew et al., 2011).
Cholinergic Modulation of Contrast
Sensitivity
We found that nicotinic as well as muscarinic blockade reduced
neuronal contrast sensitivity and the Rmax values of the contrast
response function, without (or with very little) effect on the
contrast at half maximum response (c50). This is similar to
the effects reported in previous studies, where non-specific
cholinergic agonist application resulted in changed Rmax values,
and little (or no) change to the c50 location (Disney et al.,
2012; Soma et al., 2012). Muscarinic or nicotinic activation in
V1 of the tree shrew also mostly affected Rmax and baseline
responses, with no systematic effect on c50 (Bhattacharyya et al.,
2012). Despite this overall report, Disney et al. (2007) data
appear to show an increase in c50 with nicotinic stimulation
(see their Figure 8). In our data, nicotinic blockade (rather than
stimulation) resulted in a trend toward increased c50 values,
provided only neurons significantly affected by drug application
were taken into account. This would be the opposite of what
Disney et al.’s Figure 8 shows. Small increases in c50 with
acetylcholine application were also found in rat primary visual
cortex, although there, as in primate V1, the main change
occurred in Rmax (Soma et al., 2013). Stimulation of tree shrew
basal forebrain (BF) resulted in reduced c50 and increased
Rmax values (Bhattacharyya et al., 2013). This would be largely
compatible with the data presented here, if BF stimulation
exclusively activated cholinergic cells. However, this is not the
case (Henny and Jones, 2008) and as such it is difficult to
directly compare data sets. The reduction in c50 in their data
set upon BF activation is much more pronounced than any
changes seen in our data, or the data of other studies directly
manipulating cholinergic activation in V1. This suggests that the
c50 changes were largely due to long range gabaergic influences
(or a combination of gabaergic and cholinergic effects) resulting
from BF activation.
The changes seen in neuronal activity and those seen in Rmax
were often interpreted as improving neuronal sensitivity, but
most studies did not quantitatively assess the changes. Disney
et al. (2007) assessed changes in sensitivity by finding the point
on the contrast response function were responses were reliably
outside the response range of spontaneous activity. Assessed in
this way, they found that ACh application improved contrast
sensitivity for layer IV neurons. It is not clear how this would
translate to behavioral measures. To do the latter, previous
studies have compared psychometric and neurometric functions
(e.g., Vogels and Orban, 1990; Britten et al., 1992; Thiele et al.,
2000, 2001; Luna et al., 2005; Palmer et al., 2007). In our study,
psychometric functions were not available, but neurometric
function comparison showed that muscarinic and nicotinic
blockade reduced neuronal sensitivity, although changes of the
median sensitivities were relatively modest, even if significant
across the population.
Mechanisms Affected by Nicotinic and
Muscarinic Manipulations
Most of the above cited studies interpreted the changes seen
in Rmax, and the absence of consistent changes in c50 upon
cholinergic manipulation to be a sign of altered neuronal
response gain (McAdams and Maunsell, 1999; Williford and
Maunsell, 2006) rather than contrasts gain (Reynolds et al.,
2000). However, additive gain (Thiele et al., 2009), normalization
mechanisms (Tolhurst and Heeger, 1997; Lee and Maunsell,
2009, 2010; Reynolds and Heeger, 2009; Carandini and Heeger,
2012; Ni et al., 2012; Sanayei et al., 2015), or a slope gain
(Aston-Jones and Cohen, 2005) could also account for these
effects. This has not been quantitatively addressed in any of
the previous studies. To do so we fitted 5 different models to
our data and used AIC weights to determine which model best
described the effects seen upon nicotinic or muscarinic blockade.
As expected, nicotinic receptors affect contrast sensitivity largely
by altering the response gain (74% of the cells). Normalization
mechanisms best accounted for the effects seen in only 4% of
the data, and additive or contrast gain effects best described the
effects seen in 17 and 12% of the cells. Slope gain effects best
described the data in only 4% of the cells. Very similar results
were found when manipulating muscarinic receptors. Thus,
cholinergic modulation affects response gain in ∼3/4 of the cells
in V1, while slope gain effects are very rarely seen. This argues
against the possibility that ACh could be involved in saliency
filtering, but it is rather involved in sensitivity enhancement.
Normalization mechanisms, as employed in our modeling,
best described our results in only ∼5% cells. Normalization
requires inhibitory interactions, and hence our data suggests
that this type of inhibition is not the dominant feature of
cholinergicmanipulation. At the same time, the stimuli employed
may not have been ideal to investigate this, as their size
was largely confined to the classical receptive field. Using
different sized stimuli, flanking stimuli, or cross orientation
inhibition, might yield better insight into this question. However,
contrast normalization is a well-established phenomenon in
V1 (Carandini and Heeger, 1994, 2012; Carandini et al., 1997;
Tolhurst and Heeger, 1997; Albrecht et al., 2002), and if
cholinergic mechanisms were a main driver thereof we should
have been able to uncover these with our models.
The predominance of response gain for nicotinic modulation
is predictable based on the location of nicotinic receptors on
thalamocortical terminals (Hasselmo and Bower, 1992; Gil et al.,
1997; Kimura et al., 1999; Kimura, 2000; Disney et al., 2007), and
their ability to proportionally scale input efficacy. Our data show
that muscarinic receptors also often result in overall increased
excitability, which can result in proportional scaling of inputs,
and thus response gain changes.
Whether the changes induced by muscarinic modulation are
exclusively a direct consequence of altered neuronal excitability,
or are also shaped by alteration of recurrent interactions
or feedback from higher areas by acting on pre-synaptic
M2 receptors (Kimura and Baughman, 1997) is currently
unknown. Increased excitability could be mediated by M1
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receptor activation (McCormick and Prince, 1985; McCormick,
1989). This could increase the excitability of local networks
by e.g. M-current reduction, which on its own might not
result in increased neuronal activity (we did not see changes
in spontaneous activity across our population), but it would
enhance stimulus firing rates, once neurons receive input drive.
Through activation of M2- receptors ACh would reduce the
local recurrent processing (Hasselmo and Bower, 1992; Gil et al.,
1997), but whether this would equally reduce feedback influences
from higher areas is unknown. The latter is somewhat unlikely
given that contrast sensitivity in V1 is reduced upon feedback
removal (Hupé et al., 1998). Reduction of feedback influences
by M2 receptor activation should thus result in reduced contrast
sensitivity upon ACh stimulation, while our data argue for the
opposite.
Thus, overall ACh may increases local cellular excitability,
cause a decoupling of local recurrent interactions, but
also improve integration of feedback signals terminating
predominantly in layer 1 (Rockland and Pandya, 1979).
Improved integration of feedback signals could be a result of
M-current reduction. It would allow signals arriving at the apical
dendrite in layer 1 to have more impact on signal integration at
the axon hillock. Together these effects would alter the state of
the local network, and induce changes which go beyond simple
firing rate changes, thereby improving overall coding abilities
(Minces et al., 2017; van Kempen et al., 2017).
CONCLUSIONS
Muscarinic and nicotinic receptors contribute to contrast
sensitivity of neurons in V1 in awake, passively fixating monkeys.
Blockade of these receptors reduces the maximum response
(Rmax) without affecting c50 of the contrast response function.
Additionally, neuronal thresholds are reduced as assessed by
neurometric function. By proxy, we predict that increasing
nicotinic or muscarinic drive would increase Rmax and neuronal
sensitivity, although that may depend on the characteristics of
the inverted U-curve of neuromodulation (Smucny et al., 2015).
Nicotinic and muscarinic modulation results predominantly
in proportional scaling of response functions (response gain).
Thus, the two receptors affect the local network in similar, and
seemingly cooperative ways.
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